Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Farxiga (SGLT2i) approved for CKD patients with AND without T2D

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Back To Forum List View

Farxiga (SGLT2i) approved for CKD patients with AND without T2D

barsax

May 01, 2021 03:33PM

Investalot

Rank: Treasurer [?]

Points: 360 [?]

Votes: 3 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Farxiga (SGLT2i) approved for CKD patients with AND without T2D

in response to

Farxiga (SGLT2i) approved for CKD patients with AND without T2D

barsax

posted on May 02, 2021 03:20PM

aaacchhhhh,,,,,,,at least someone is getting an approval on CKD related drugs and the like. Narmac I apologize for using your expression but I think it describes our situation well.

2 Recommendations

Re: Farxiga (SGLT2i) approved for CKD patients with AND without T2D

narmac

May 02, 2021 09:44PM

Re: Farxiga (SGLT2i) approved for CKD patients with AND without T2D

KOO-KOO2

May 03, 2021 05:57AM

Re: Farxiga (SGLT2i) approved for CKD patients with AND without T2D

narmac

May 03, 2021 07:11AM

Re: Farxiga (SGLT2i) approved for CKD patients with AND without T2D

KOO-KOO2